CDT EQUITY INC. Retained Earnings
CDT EQUITY INC. (CDT) had Retained Earnings of -$77.03 million as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-08
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$77.03M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$72.39M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$68.33M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$47.00M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$77.03M S-1 · filed 2026-09-08 | |
| 2026-03-31 | -$72.39M 10-Q · filed 2026-07-15 | |
| 2025-12-31 | -$68.33M S-1 · filed 2026-09-08 | |
| 2025-09-30 | -$47.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$39.88M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$33.85M 10-Q/A · filed 2025-08-14 | -$34.25M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$29.10M S-1 · filed 2026-09-08 | |
| 2024-09-30 | -$26.70M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$20.23M 10-Q/A · filed 2024-11-14 | |
| 2024-03-31 | -$14.85M 10-Q/A · filed 2024-11-14 | |
| 2023-12-31 | -$11.30M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$11.54M 10-Q · filed 2024-11-14 | -$13.08M 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$14.18M 10-Q/A · filed 2024-11-14 | -$6.07M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$12.44M 10-Q/A · filed 2024-11-14 | -$5.48M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$10.77M 10-K · filed 2024-04-16 | -$4.30M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$3.70M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$3.30M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$3.08M 10-Q · filed 2022-05-18 | |
| 2021-12-31 | -$4.38K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |